The Efficacy of Fibrinogen Concentrate Compared to Cryoprecipitate in Major Obstetric Haemorrhage – an Observational Study. Authors
نویسندگان
چکیده
Background Fibrinogen replacement is critical in major obstetric haemorrhage (MOH).Purified, pasteurized fibrinogen concentrate appears to have benefitover cryoprecipitate in ease of administration and safety but is unlicensed in pregnancy. In July 2009 the Irish Blood Transfusion Service replaced cryoprecipitate with fibrinogen.
منابع مشابه
The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia
Massive obstetric haemorrhage remains a major cause of maternal death attributable to hypofibrinogenaemia. Transfusion of large volumes of fresh frozen plasma (FFP) is required to normalise fibrinogen levels. We compared the efficacy of FFP (F group) with that of FFP plus fibrinogen concentrate (F + F group) in massive obstetric haemorrhage. In this retrospective study, we compared the medical ...
متن کاملCryoprecipitate therapy
Cryoprecipitate, originally developed as a therapy for patients with antihaemophilic factor deficiency, or haemophilia A, has been in use for almost 50 yr. However, cryoprecipitate is no longer administered according to its original purpose, and is now most commonly used to replenish fibrinogen levels in patients with acquired coagulopathy, such as in clinical settings with haemorrhage includin...
متن کاملFibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial
BACKGROUND Postpartum haemorrhage (PPH) is a major cause of maternal morbidity. Bleeding is caused by a combination of physical causes, such as failure of the uterus to contract or operations, and is made worse by impairment of the blood clotting system. A number of studies have shown that low levels of the blood clotting factor fibrinogen are associated with progression of bleeding, the need f...
متن کاملFibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial
BACKGROUND Haemorrhage is a leading cause of death in severe trauma. Fibrinogen plays a critical role in maintaining haemostasis in traumatic haemorrhage. Early fibrinogen replacement is recommended by several international trauma guidelines using either fibrinogen concentrate (FC) or cryoprecipitate (Cryo). There is limited evidence to support one product over the other with widespread geograp...
متن کاملBlood transfusion and the anaesthetist: management of massive haemorrhage
1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised immediately when a massive haemorrhage situation is declared. 4. A fibrinogen < 1 g.l or a prothromb...
متن کامل